Atlas Trials

A Study of Intranasal Live Attenuated Influenza Vaccine Immunogenicity and Associations With the Nasopharyngeal Microbiome Among Children in the Gambia

Clinical trial NCT02972957 · COMPLETED

Trial details

NCT number
NCT02972957
Sponsor
London School of Hygiene and Tropical Medicine
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Influenza
Start date
2017-01-30
Primary completion
2018-12-19
Enrollment
364

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.